eloproliferative disorders (MPD) is believed to be secondary to autonomous unregulated platelet production. Secondary or re-active thrombocytosis (RT) can be observed in a number of clinical circumstances and may be related to persistent produc-tion of some thrombopoietic factors acting on megakaryocytes (MK). The goal of this study is to assess the serum concentra-tions of these cytokines in control subjects and patients with MPD associated with thrombocythemia, RT, and autoimmune thrombocytopenic purpura (ATP). Eleven patients with MPD, five with chronic myeloid leukemia (CML), three with poly-cythemia vera (PCV), two with essential thrombocythemia (ET), one with myelofibrosis, 15 with RT, eight with ATP, and 12 healthy volunteers were en...
Although the molecular pathways that cause acute myeloid leukemia (AML) are increasingly well unders...
International audience: Studies have shown that the clinical impact of JAK2 inhibitors in primary my...
Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production ...
The myeloproliferative disorders have been the “poor cousins ” in the family of hematological malign...
Bleeding and thrombosis in myeloproliferative disorders (MPD) are common events, sometimes both are ...
textabstractThrombocytosis, i.e. an elevation of the platelet count, is a common finding in clinical...
The thrombophilic state of patients with myeloproliferative disorders (MPD) is associated with comp...
An underlying myeloproliferative disorder (MPD), especially polycythemia vera (PV) or essential thro...
Thrombocytosis has a large number of potential underlying causes, but the dominant group of hematolo...
Human c-mpl ligand or thrombopoietin (TPO) has been proved to be a critical cytokine in the physiolo...
eactive thrombocytosis (ST) occurs as a non specific response to chronic, inflam-matory or neoplasti...
Although the chronic myeloproliferative disorders (MPDs) polycythaemia vera (PV) and essential throm...
In this thesis mechanisms of thrombocytopenia (a low number of platelets) in patients with myelodysp...
Essential thrombocythaemia (ET) can be difficult to discriminate from an occult case of reactive thr...
The myeloproliferative disorders (MPDs) are clonal haematological malignancies comprising three main...
Although the molecular pathways that cause acute myeloid leukemia (AML) are increasingly well unders...
International audience: Studies have shown that the clinical impact of JAK2 inhibitors in primary my...
Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production ...
The myeloproliferative disorders have been the “poor cousins ” in the family of hematological malign...
Bleeding and thrombosis in myeloproliferative disorders (MPD) are common events, sometimes both are ...
textabstractThrombocytosis, i.e. an elevation of the platelet count, is a common finding in clinical...
The thrombophilic state of patients with myeloproliferative disorders (MPD) is associated with comp...
An underlying myeloproliferative disorder (MPD), especially polycythemia vera (PV) or essential thro...
Thrombocytosis has a large number of potential underlying causes, but the dominant group of hematolo...
Human c-mpl ligand or thrombopoietin (TPO) has been proved to be a critical cytokine in the physiolo...
eactive thrombocytosis (ST) occurs as a non specific response to chronic, inflam-matory or neoplasti...
Although the chronic myeloproliferative disorders (MPDs) polycythaemia vera (PV) and essential throm...
In this thesis mechanisms of thrombocytopenia (a low number of platelets) in patients with myelodysp...
Essential thrombocythaemia (ET) can be difficult to discriminate from an occult case of reactive thr...
The myeloproliferative disorders (MPDs) are clonal haematological malignancies comprising three main...
Although the molecular pathways that cause acute myeloid leukemia (AML) are increasingly well unders...
International audience: Studies have shown that the clinical impact of JAK2 inhibitors in primary my...
Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production ...